PRIGX
Price
$17.67
Change
-$0.28 (-1.56%)
Updated
Sep 6 closing price
PRIKX
Price
$14.57
Change
-$0.17 (-1.15%)
Updated
Sep 6 closing price
Ad is loading...

PRIGX vs PRIKX

Header iconPRIGX vs PRIKX Comparison
Open Charts PRIGX vs PRIKXBanner chart's image
T. Rowe Price Glbl Val Eq Cl I
Price$17.67
Change-$0.28 (-1.56%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Real Assets I
Price$14.57
Change-$0.17 (-1.15%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PRIGX vs PRIKX Comparison Chart
Loading...
VS
PRIGX vs. PRIKX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRIGX is a Buy and PRIKX is a Buy.

FUNDAMENTALS
Fundamentals
PRIKX has more cash in the bank: 10.5B vs. PRIGX (139M). PRIKX pays higher dividends than PRIGX: PRIKX (1.87) vs PRIGX (1.59). PRIGX was incepted earlier than PRIKX: PRIGX (12 years) vs PRIKX (9 years). PRIGX (67.60) and PRIKX (65.10) have comparable annual turnover. PRIGX (500000) and PRIKX (500000) have matching initial minimum investment requirements. PRIGX annual gain was more profitable for investors over the last year : 20.35 vs. PRIKX (10.94). PRIGX return over 5 years is better than : 58.08 vs. PRIKX (43.27).
PRIGXPRIKXPRIGX / PRIKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years9 years-
Gain YTD12.9645.061256%
Front LoadN/AN/A-
Min. Initial Investment500000500000100%
Min. Initial Investment IRAN/AN/A-
Net Assets139M10.5B1%
Annual Yield % from dividends1.591.8785%
Returns for 1 year20.3510.94186%
Returns for 3 years11.645.17225%
Returns for 5 years58.0843.27134%
Returns for 10 years38.80N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AU28.880.35
+1.23%
AngloGold Ashanti plc
ELDN2.590.01
+0.39%
Eledon Pharmaceuticals
JMIA4.37N/A
N/A
Jumia Technologies AG
SPNT14.47-0.09
-0.62%
SiriusPoint Ltd
APVO0.34-0.02
-5.07%
Aptevo Therapeutics